SCHEMBL30689317

SCHEMBL30689317

FC(F)(F)c1cc(Oc2ccc(-c3noc(CCl)n3)cc2)ccn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC4 P56524 1/20 0.41
▸ HDAC6 Q9UBN7 1/20 0.41
▸ S1PR1 P21453 3/20 0.41
▸ S1PR3 Q99500 2/20 0.41
▸ LMNA P02545 2/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ GSTP1 P09211 3/20 0.39
▸ FFAR1 O14842 1/20 0.39
▸ TSHR P16473 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ ACACB O00763 2/20 0.39
▸ NPY1R P25929 1/20 0.39
▸ NPY2R P49146 1/20 0.39
▸ ACACA Q13085 1/20 0.39
▸ LTA4H P09960 1/20 0.39
▸ KCNH2 Q12809 1/20 0.39
▸ SIRT2 Q8IXJ6 2/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30689333 0.81 GSTP1 (0.43) HDAC4HDAC6LMNAGSTP1FFAR1
SCHEMBL30689327 0.78 GSTP1 (0.42) HDAC4HDAC6LMNARAB9AGSTP1
SCHEMBL30689322 0.75 LMNA (0.47) S1PR1S1PR3LMNAGSTP1FFAR1
SCHEMBL29077239 0.75 S1PR1 (0.55) S1PR1S1PR3NPC1RAB9ATSHR
SCHEMBL2356588 0.73 S1PR1 (0.65) S1PR1S1PR3LMNAMAPTSIRT2
SCHEMBL27894825 0.72 LOXL2 (0.50) —
SCHEMBL27207676 0.71 TP53 (0.64) LMNANPC1RAB9ATSHRMAPT
SCHEMBL1220782 0.70 SMN1; SMN2 (0.66) S1PR1LMNANPC1RAB9ATSHR
SCHEMBL15495457 0.70 KCNQ1 (0.47) HDAC4HDAC6S1PR1S1PR3MAPT
SCHEMBL22637250 0.70 LOXL2 (0.49) HDAC4HDAC6S1PR1S1PR3KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119968366-A Oxadiazole derivatives, methods of preparation and use thereof in the treatment of inflammatory diseases 西特瑞治疗有限公司 2025-05-09 — — CN disclosed
EP-4543875-A1 OXADIAZOLE DERIVATIVES, PREPARATION PROCESS THEREOF AND THEIR USE IN TREATING INFLAMMATORY DISEASES Sitryx Therapeutics Limited (GB) 2025-04-30 — — EP disclosed
WO-2023247958-A1 OXADIAZOLE DERIVATIVES, PREPARATION PROCESS THEREOF AND THEIR USE IN TREATING INFLAMMATORY DISEASES SITRYX THERAPEUTICS LIMITED (GB) 2023-12-28 — — WO disclosed
Send feedback